Clinical Trials Directory

Trials / Completed

CompletedNCT04042233

Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
The Methodist Hospital Research Institute · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate a novel vancomycin intraosseous administration protocol vs a standard IV vancomycin administration protocol for primary total hip arthroplasty patients.

Detailed description

Patients are randomized to one of two groups. GROUP A - Will receive IV antibiotics (cefepime \& vancomycin) are started in pre-op approximately 1 hour prior to incision vancomycin dose weight-based at approximately 15mg/kg, generally 1000-1750mg in 500 milliliters (mL) normal saline (NS). GROUP B - Will have IV cefepime started in pre-op within 1 hour of incision. Intraosseous (IO) administration of vancomycin (500mg in 250 milliliters NS) will be administered in the OR after sterile prep and draping has occurred. Injection will take place into the greater trochanter (within a pre-specified region). Both Groups will be monitored during surgery and immediately post-operatively for adverse injection reactions (i.e. Red Man Syndrome). Both groups will otherwise follow identical post-operative protocols (including post-operative antibiotic administration). TISSUE SAMPLES Five (5) tissue samples will be taken from each patient, 2 soft tissue samples and 3 bone samples will be taken throughout the course of the procedure. One blood sample will be taken in both groups intraoperatively at the time of initiation of closure. These samples will immediately be sent to a lab for analysis.

Conditions

Interventions

TypeNameDescription
DRUGExperimental Intraosseous vancomycin 500mg in 250 mL NS500mg of Vancomycin in 250 mL of normal saline will be injected into a pre-specified region of the greater trochanter during primary total hip arthroplasty.
DRUGStandard IV administration of vancomycinIV antibiotics (cefepime \& vancomycin) are started in pre-op approximately 1 hour prior to incision (vancomycin dose weight-based at approximately 15mg/kg, generally 1000-1750mg in 500 mL NS).

Timeline

Start date
2019-12-31
Primary completion
2022-05-25
Completion
2022-09-01
First posted
2019-08-01
Last updated
2025-03-13
Results posted
2025-03-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04042233. Inclusion in this directory is not an endorsement.